Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Océane Pointeau

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cells|June 11, 2025
HSP110 Regulates the Assembly of the SWI/SNF ComplexOcéane Pointeau, Manon Paccagnini, Natalia Borges-Bonan, et al.
International Journal of Molecular Sciences|March 27, 2025
A Simplified and Robust Model for the Study of Diabetic Nephropathy: Streptozotocin-Induced Diabetic Mice Fed a High-Protein DietOcéane Pointeau, Romain Barbosa, Maéva Loriot, et al.
Journal of Medicinal Chemistry|October 11, 2025
Leveraging Peripheral CB1 Antagonism in 1,4,5,6-Tetrahydropyridazine-Based Amidine Substituted Sulfonyl Analogs for Treating Metabolic DisordersPinaki Bhattacharjee, Szabolcs Dvorácskó, Paul Volesky, et al.
Metabolism: Clinical and Experimental|May 14, 2025
Evaluation of tetrahydropyridazine-based peripherally restricted dual inhibitors of CB1R and inducible nitric oxide synthase (iNOS) for treating metabolic syndrome disordersPinaki Bhattacharjee, Szabolcs Dvorácskó, Océane Pointeau, et al.
Frontiers in Nephrology|September 7, 2023
Therapeutic potential of a novel peripherally restricted CB1R inverse agonist on the progression of diabetic nephropathyLaetitia Jacquot, Océane Pointeau, Célia Roger-Villeboeuf, et al.
British Journal of Pharmacology|July 12, 2025
Blockade of cannabinoid CB<sub>1</sub> receptors potentiates the anti-fibrotic effects mediated by SGLT2 inhibition in a mouse model of diabetic nephropathyOcéane Pointeau, Awa Isma Ba, Audrey Geissler, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cells|June 11, 2025
HSP110 Regulates the Assembly of the SWI/SNF ComplexOcéane Pointeau, Manon Paccagnini, Natalia Borges-Bonan, et al.
International Journal of Molecular Sciences|March 27, 2025
A Simplified and Robust Model for the Study of Diabetic Nephropathy: Streptozotocin-Induced Diabetic Mice Fed a High-Protein DietOcéane Pointeau, Romain Barbosa, Maéva Loriot, et al.
Journal of Medicinal Chemistry|October 11, 2025
Leveraging Peripheral CB1 Antagonism in 1,4,5,6-Tetrahydropyridazine-Based Amidine Substituted Sulfonyl Analogs for Treating Metabolic DisordersPinaki Bhattacharjee, Szabolcs Dvorácskó, Paul Volesky, et al.
Metabolism: Clinical and Experimental|May 14, 2025
Evaluation of tetrahydropyridazine-based peripherally restricted dual inhibitors of CB1R and inducible nitric oxide synthase (iNOS) for treating metabolic syndrome disordersPinaki Bhattacharjee, Szabolcs Dvorácskó, Océane Pointeau, et al.
Frontiers in Nephrology|September 7, 2023
Therapeutic potential of a novel peripherally restricted CB1R inverse agonist on the progression of diabetic nephropathyLaetitia Jacquot, Océane Pointeau, Célia Roger-Villeboeuf, et al.
British Journal of Pharmacology|July 12, 2025
Blockade of cannabinoid CB<sub>1</sub> receptors potentiates the anti-fibrotic effects mediated by SGLT2 inhibition in a mouse model of diabetic nephropathyOcéane Pointeau, Awa Isma Ba, Audrey Geissler, et al.
Pageof 1